Lumosa Therapeutics Co. Ltd. (6535.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
Lumosa Therapeutics Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 39.15 m TWD | 35.83 m TWD |
| Gross profit | 17.71 m TWD | 21.87 m TWD |
| Operating income | -356.94 m TWD | -333.50 m TWD |
| EBIT | -436.65 m TWD | -346.42 m TWD |
| Net income | -424.78 m TWD | -340.54 m TWD |
| Diluted EPS – continuing operations | -2.52 TWD | -2.02 TWD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lumosa Therapeutics Co. Ltd.
Lumosa Therapeutics Co., Ltd., a clinical-stage pharmaceutical company, develops drugs for neurological and oncological diseases in Taiwan and the rest of Asia. The company offers Naldebain (LT-1001), an analgesic injection for postoperative pain. It also develops LT3001, which has completed Phase 2b clinical trials for the treatment of acute ischemic stroke; LT6001, which is in pre-clinical trials for the treatment of neurological disorders; and CS028, which is in the pre-clinical stage for the treatment of solid tumors. In addition, the company engages in the investment, new drug development consulting, and service and transfer of techniques activities. The company was formerly known as SunTen Phytotech Co., Ltd. and changed its name to Lumosa Therapeutics Co., Ltd. in June 2014. Lumosa Therapeutics Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.
More stocks
- TRANSCONTINENTAL REALTY INVESTORS INC (TCI)
- Fidere Patrimonio SOCIMI SA (YFID.MC)
- NATHANS FAMOUS, INC. (NATH)
- AdvanSix Inc. (ASIX)
- PUMA BIOTECHNOLOGY, INC. (PBYI)
- BFF Bank SpA (BFF.MI)
- Don Muang Tollway Public Company Limited (DMT.BK)
- Wanma Technology Co Ltd (300698.SZ)
- LAY-OUT Planning Consultants Co. Ltd. (300989.SZ)
- Isoenergy Ltd (ISO.TO)
- All for One Group (A1OS.DE)
- Jiangxi Synergy Pharmaceutical Co Ltd (300636.SZ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.